NCT04618224

Brief Summary

Primary objective of our study is to develop and validate an internet-based digital near and intermediate-vision reading test in the greek language.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2020

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 5, 2020

Completed
27 days until next milestone

Study Start

First participant enrolled

December 2, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2021

Completed
Last Updated

February 16, 2021

Status Verified

February 1, 2021

Enrollment Period

1 month

First QC Date

October 31, 2020

Last Update Submit

February 12, 2021

Conditions

Keywords

internet-based digital reading testsmart featuresface detectionreading acuityreading speedcritical print size

Outcome Measures

Primary Outcomes (4)

  • Reading Acuity (RA)

    The smallest print that can be read by the patient easily (measured in logMAR). It is calculated by the following formula: RA = 1.4 - (sentences x 0.1) + (errors x 0.01).

    through study completion, an average of 3 months

  • Maximum Reading Speed (MRS)

    The patient's reading speed (measured in wpm) when reading is not limited by print size. It is calculated by averaging the reading speed of the sentences with print size larger than the CPS.

    through study completion, an average of 3 months

  • Critical Print Size (CPS)

    The smallest print size (measured in logMAR) that can be read with the MRS, i.e., with speed greater than or equal to the average reading speed of the larger logMAR print sentences minus 1.96 times the standard deviation (SD) of the reading speed of these sentences.

    through study completion, an average of 3 months

  • Accessibility Index (ACC)

    The mean reading speed of the 10 largest print sizes at 40 cm (1.3 to 0.4 logMAR), divided by 200 wpm, which is the mean reading speed of normally sighted young adults aged 18 to 39 years old. This parameter was designed for better evaluation of one's access to text across the range of the 10 most common print sizes found in everyday life. For instance, a value of 0 means no access to commonly encountered printed material, while 1.0 is the mean value for normally sighted young adults that indicates reading fluency within the everyday life print sizes.

    through study completion, an average of 3 months

Secondary Outcomes (1)

  • Intraclass Correlation Coefficients (ICCs) for study participants

    through study completion, an average of 3 months

Other Outcomes (1)

  • Test-retest Intraclass Correlation Coefficients (ICCs)

    through study completion, an average of 3 months

Study Arms (2)

Control group

* 70 patients with normal vision (NVG) with adequate literacy of written Greek language * 30 patients with low vision (LVG) with adequate literacy of written Greek language These patients are tested on the digital reading test DDART.

Diagnostic Test: DDART Testing

Study group

The same patients as those in the control group (NVG, LVG) are tested on the online version of the Greek digital reading test DDART (wDDART).

Diagnostic Test: wDDART Testing

Interventions

DDART TestingDIAGNOSTIC_TEST

One randomly selected eye is included for each study participant. Participants respond to the DDART near vision test with defined environmental conditions at 40 cm viewing distance. All four parameters (RA, MRS, CPS and ACC) are evaluated.

Control group
wDDART TestingDIAGNOSTIC_TEST

One randomly selected eye is included for each study participant. Participants respond to the wDDART near vision test with defined environmental conditions at 40 cm viewing distance. All four parameters (RA, MRS, CPS and ACC) are evaluated.

Study group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Normal- and low-sighted participants aged 18 to 75 years

You may qualify if:

  • Adequate literacy of written Greek language
  • Age between 18 to 75 years

You may not qualify if:

  • Dyslexia
  • Attention-deficiency
  • Former diagnosis of mental and/or psychiatric diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Ophthalmology, University Hospital of Alexandroupolis

Alexandroupoli, Evros, 68100, Greece

Location

Department of Computer Science and Biomedical Informatics, University of Thessaly

Lamía, Thessaly, 35100, Greece

Location

Related Publications (2)

  • Labiris G, Panagiotopoulou EK, Chatzimichael E, Tzinava M, Mataftsi A, Delibasis K. Introduction of a digital near-vision reading test for normal and low vision adults: development and validation. Eye Vis (Lond). 2020 Oct 22;7:51. doi: 10.1186/s40662-020-00216-0. eCollection 2020.

  • Labiris G, Panagiotopoulou EK, Duzha E, Tzinava M, Perente A, Konstantinidis A, Delibasis K. Development and Validation of a Web-Based Reading Test for Normal and Low Vision Patients. Clin Ophthalmol. 2021 Sep 22;15:3915-3929. doi: 10.2147/OPTH.S314943. eCollection 2021.

MeSH Terms

Conditions

PresbyopiaRefractive ErrorsVision, LowMyopia

Condition Hierarchy (Ancestors)

Eye DiseasesVision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Georgios Labiris, MD, PhD

    Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor (Associate) of Democritus University of Thrace

Study Record Dates

First Submitted

October 31, 2020

First Posted

November 5, 2020

Study Start

December 2, 2020

Primary Completion

January 15, 2021

Study Completion

February 10, 2021

Last Updated

February 16, 2021

Record last verified: 2021-02

Locations